EUVIMEDEUVIMED entdecken
Open Access

Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study

Fei Gong iD, Liyun Zheng iD, Jiachen Xu iD, Yumin Wu, Qiutong Jin, Jiaqi Lu, Zifan Pei iD, Zhongwei Zhao, Minjiang Chen, Jianfei Tu, Shiji Fang, Weiqian Chen und 9 weitere

Science Advances · 04.07.2025 · 11 (27)

DOI: 10.1126/sciadv.adv0885 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 04.07.2025. Verfasst von Fei Gong und 20 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Microspheres, Liver Neoplasms. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Transarterial chemoembolization (TACE) has been extensively used in clinic to treat unresectable hepatocellular carcinoma (HCC). Herein, magnesium microspheres (Mg MSs) were used as embolic devices to enhance lipiodol-mediated TACE. After being dispersed in lipiodol and injected into tumors, Mg MSs would continuously generate hydrogen and magnesium hydroxide, which could neutralize the acidic tumor microenvironment, restore exhausted CD8 + T cells, reverse immunosuppression, and trigger specific T cell–mediated antitumor responses, synergistically resulting in inhibited tumor growth. As demonstrated in a rabbit orthotopic liver cancer model, artery infusion of Mg MS–dispersed lipiodol offered greatly enhanced therapeutic outcome compared to lipiodol-based or polymeric-bead–based TACE. In a pilot clinical study, among 15 eligible patients with HCC, 11 patients achieved complete response and 3 patients achieved partial responses without unexpected treatment-related adverse events during the 1 to 3 months’ follow-up. The objective response rate of Mg-enhanced TACE was ~93.3% in this small-scale trial, much higher than that of current TACE therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularChemoembolization, TherapeuticMicrospheresLiver NeoplasmsMagnesiumAnimalsHumansPilot ProjectsMaleFemaleMiddle AgedAgedRabbitsTreatment OutcomeDisease Models, AnimalEthiodized Oil

Substanzen

MagnesiumEthiodized Oil

Autor:innen und Institutionen

  • Institute of Functional Nano & Soft Materials (FUNSOM), Jiangsu Key Laboratory for Carbon-Based Functional Materials and Devices, Soochow University, Suzhou 215123, China.
  • Department of Interventional Radiology, Zhejiang University Lishui Hospital, The Fifth Affiliated Hospital of Wenzhou Medical University, Lishui Central Hospital, Lishui 323000, China.
  • Department of Vascular Surgery and Interventional Radiology, The Fourth Affiliated Hospital of Soochow University, Du Shu Lake Hospital Affiliated to Soochow University, Suzhou 215125, China.
  • Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • InnoBM Pharmaceuticals Co. Ltd., Suzhou, Jiangsu 215123, China.

ORCID-Profile: Fei Gong, Liyun Zheng, Jiachen Xu, Zifan Pei, Nailin Yang, Caifang Ni, Liang Cheng, Zhuang Liu, Jiansong Ji

Zitieren

APA

Gong, F., Zheng, L., Xu, J., Wu, Y., Jin, Q., Lu, J., Pei, Z., Zhao, Z., Chen, M., Tu, J., Fang, S., Chen, W., Wei, K., Yang, N., Gong, C., Wu, F., Zhang, Y., Ni, C., Cheng, L., …, & Ji, J. (2025). Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study. Science Advances, 11(27). https://doi.org/10.1126/sciadv.adv0885

Vancouver

Gong F, Zheng L, Xu J, Wu Y, Jin Q, Lu J, et al. Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study. Science Advances. 2025;11(27). doi:10.1126/sciadv.adv0885

BibTeX
@article{Gong2025,
  author = {Gong, Fei and Zheng, Liyun and Xu, Jiachen and Wu, Yumin and Jin, Qiutong and Lu, Jiaqi and Pei, Zifan and Zhao, Zhongwei and Chen, Minjiang and Tu, Jianfei and Fang, Shiji and Chen, Weiqian and Wei, Kailu and Yang, Nailin and Gong, Chuntao and Wu, Fazong and Zhang, Yeyu and Ni, Caifang and Cheng, Liang and Liu, Zhuang and Ji, Jiansong},
  title = {Magnesium microspheres for enhanced transarterial chemoembolization therapy of hepatocellular carcinoma: From animal models to a pilot clinical study},
  journal = {Science Advances},
  year = {2025},
  volume = {11},
  number = {27},
  doi = {10.1126/sciadv.adv0885}
}
Kostenlos starten →